Improving immune reconstitution while preventing GvHD in allogeneic stem cell transplantation
Authors:
- 1 May 2005
- journal article
- review article
- Published by Elsevier in Cytotherapy
- Vol. 7 (2) , 102-108
Abstract
Allogeneic hematopoietic stem cell transplantation (HSCT) is the treatment of choice for many hematologic malignancies and inherited disorders of the hematopoietic system. Ex vivo T-cell depletion (TCD) of the graft and post-transplantation immunosuppression efficiently prevents the development of GvHD in no- MHC-identical settings. However, the consequence of these non-specific strategies is a long-lasting immunodeficiency associated with increased incidence of disease relapse, graft rejection and reactivation of viral infections. Donor lymphocyte infusion, which is used for treating leukemic relapse after allogeneic HSCT, can result in severe GvHD. Several strategies are being optimized specifically to inactivate anti-host T cells while preserving anti-leukemic or anti-microbial immunocompetence. Based on the ex vivo or in vivo elimination of anti-host Tcells, or on the modulation of their anti-host activity, these approaches, which have been explored extensively in pre-clinical studies and tested in some preliminary clinical trials, are discussed in this paper.Keywords
This publication has 61 references indexed in Scilit:
- IL‐7 effect on immunological reconstitution after HSCT depends on MHC incompatibilityBritish Journal of Haematology, 2004
- Ex vivo depletion of alloreactive cells based on CFSE dye dilution, activation antigen selection, and dendritic cell stimulationBlood, 2004
- Common lymphoid progenitors rapidly engraft and protect against lethal murine cytomegalovirus infection after hematopoietic stem cell transplantationBlood, 2003
- CD4+CD25+ Immunoregulatory T CellsJournal of Experimental Medicine, 2002
- P-glycoprotein targeting: a unique strategy to selectively eliminate immunoreactive T cellsBlood, 2002
- Adenovirus Infections in Hematopoietic Stem Cell Transplant RecipientsClinical Infectious Diseases, 1999
- Selective removal of alloreactive cells from haematopoietic stem cell grafts: graft engineering for GVHD prophylaxisBone Marrow Transplantation, 1999
- Infections in adults undergoing unrelated donor bone marrow transplantationBritish Journal of Haematology, 1999
- Specific depletion of alloreactive T cells in HLA‐identical siblings: a method for separating graft‐versus‐host and graft‐versus‐leukaemia reactionsBritish Journal of Haematology, 1998
- Immunotoxins constructed with anti‐CD25 monoclonal antibodies and deglycosylated ricin a‐chain have potent anti‐tumour effects against human hodgkin cells in vitro and solid hodgkin tumours in miceInternational Journal of Cancer, 1991